CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Prioritize Children’s Health: 2026 Policy Priorities for Federal Policymakers
Hopeful Conversations to End the Youth Mental Health Crisis
Securing the Workforce That Cares for America’s Children
Prioritize Children’s Health: 2026 Policy Priorities for Federal Policymakers
As Congress and the administration develop health care policies, we encourage them to consider the unique needs of children and the children's hospitals that serve them.
Feb. 10, 2026
Hopeful Conversations to End the Youth Mental Health Crisis
The Speak Our Minds podcast shares what lies ahead on the road to better mental health care for children.
Feb. 10, 2026
Securing the Workforce That Cares for America’s Children
A strong pediatric workforce is essential. CHA created a blueprint to guide federal policy solutions.
Feb. 09, 2026
